China (Mainland)
98% N-Fmoc--L-serine CAS NO.73724-45-5
- Min.Order: 1 Gram
- Payment Terms: T/T
- Product Details
Keywords
- 98% N-Fmoc--L-serine
- 98% 73724-45-5
- N-Fmoc--L-serine Supplier
Quick Details
- ProName: 98% N-Fmoc--L-serine
- CasNo: 73724-45-5
- Molecular Formula: C18H17NO5
- Appearance: white powder
- Application: Used in biochemical reagents and pepti...
- DeliveryTime: Within ten working day
- PackAge: according to the clients requirement
- Port: Shang hai
- ProductionCapacity: 100 Kilogram/Month
- Purity: 98%
- Storage: 2-8°C
- Transportation: by sea or by air
- LimitNum: 1 Gram
Superiority
CAS number: 73724-45-5
Molecular formula: C18H17NO5
Molecular weight: 327.34
Appearance: white crystalline powder
Melting point: 86～88℃
Specific rotation: -11.5～-13.5° (c=1, DMF)
Purity: ≥98.5% (HPLC)
For biochemical reagents, peptide synthesis
Storage conditions: 2-8°C
1) We are a manufacturer and can provide high-quality products at ex-factory prices.
2) Fast and safe delivery, safe and prudent transportation, you can choose a variety of transportation methods.
3) Professional service and rich experience can make customers feel at ease, with sufficient inventory and fast delivery to meet your needs.
Details
Suzhou Yi Peter Biotechnology Co., Ltd. was established in July 2016 with a registered capital of 5 million yuan. It is a company that develops and produces high-end cosmetic raw materials and new biological materials.
In 2017, it was rated as a private technology enterprise in Jiangsu Province. In the same year, the company was rated as a leading talent enterprise in Yangcheng Lake by the Suzhou government.
In 2018, the company obtained a utility model patent certificate, patent authorization announcement number: CN206965725U
In 2019, the company obtained a utility model patent certificate, patent authorization announcement number: CN208194394U
In 2019, the company won the patent for invention of new biological materials, patent authorization announcement number: CN107056834B
At present, advanced cultivation and storage have been completed.
The company already has more than ten invention patents and five utility model patents.
The company's products have entered overseas markets and the goal is to break the monopoly of high-end biomaterials in Japan and the United States.
At present, the company has jointly developed a new generation of products with scientific research institutions such as the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, which has laid the foundation for the company's long-term development.